Sponsors must be aware of common mistakes registering with the TGA in 2025 to prevent costly delays. The Therapeutic Goods Administration continues to refine submission expectations, making accuracy and preparation more critical than ever.
Mistakes That Could Delay Your 2025 TGA Submission
Many sponsors underestimate how seemingly minor oversights can affect approval timelines. Common mistakes include:
- Submitting outdated manufacturer’s evidence
- Misclassifying the device based on outdated criteria
- Overlooking the latest TGA guidance
- Providing inconsistent technical documentation
Each of these can result in clarification requests or application rejection, increasing the time and cost of getting to market.
How to Strengthen Your Submission
Understanding the TGA registration process in 2025 helps you avoid avoidable errors. Start by checking the GMDN code and confirming the correct medical device classification based on intended use. Also, ensure your manufacturer’s evidence is up-to-date and clearly structured.
All supporting documents — such as clinical summaries, Essential Principles checklists, and labelling — must be consistent throughout submission. Even minor discrepancies can raise compliance concerns during a review.
To reduce risk, many manufacturers choose to partner with a medical device consultant or sponsor who understands current TGA expectations and can help align each component of the application before submission.
Submission Success Starts with Preparation
Addressing these common mistakes when registering with the TGA in 2025 will improve your chances of first-pass approval. Use the current TGA registration process as a reference point, prepare thoroughly to support a timely outcome, and partner with an experienced medical device consultant.